ScaleReady Announces a G-Rex® Grant has been awarded to Xellera Therapeutics. ST. PAUL, Minn., 6 August, 2025
Summary
ScaleReady awarded Xellera Therapeutics a US$150,000 G-Rex Grant to support development of a cGMP-centric NK cell manufacturing platform in Hong Kong. Xellera will use the grant to expand its CDMO capabilities and build a feeder-free, xeno-free, closed-system process for scalable allogeneic cell therapy production. The company says the new platform will complement its existing CAR-T and iPSC capabilities and support client programs from early development through commercial readiness. ScaleReady says this is its first grant award in Hong Kong and expects the collaboration to accelerate advanced cell therapy access across Asia-Pacific.
Classifications
industries
Manufacturing Industry
applications
Manufacturing Software
AskAI Classifications
Labels
No AI classifications detected